HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Finance In Brief

This article was originally published in The Rose Sheet

Executive Summary

Revlon Q3: Improvement in sales returns and higher shipments of beauty care, primarily women's hair color, boosted U.S. sales during the third quarter 19.7% to $190.9 mil., Revlon says during a Q3 earnings call Nov. 6. However, Vital Radiance negatively impacted sales by $15 mil., the firm notes. As part of a recovery plan for 2008, Revlon will introduce a slew of new products in the first half, including ColorStay Minerals, "the first-ever longwearing minerals collection in the mass market" as well as Revlon Custom Creations Foundation and Almay foundations, makeup remover and other products. Net sales grew 11% to $339.7 mil., and the firm experienced a net loss of $10.4 mil. compared with a net loss of $100.5 mil. in the prior-year quarter...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015069

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel